Urgent.News

What's breaking now, across thousands of outlets.

Business

Ecobank JoyBusiness SME Fair 2026: Day Two kicks off with exciting bargains, irresistible deals at Ghud Park

The shopping excitement is back, the bargains are calling and the opportunities to discover Ghanaian-made products are getting even bigger as Day Two of the Ecobank JoyBusiness SME Fair 2026 gets underway at Ghud Park, Accra Mall.

Ecobank JoyBusiness SME Fair 2026: Day Two kicks off with exciting bargains, irresistible deals at Ghud Park

The Ecobank JoyBusiness SME Fair 2026 continued its festive spirit on the second day, with shoppers flocking to Ghud Park, Accra Mall to take advantage of the countless bargains and irresistible deals on offer. Over 80 brands exhibited a diverse array of products and services, promising an exhilarating day for families, entrepreneurs, and anyone seeking quality items at competitive prices.

Those who missed the exhibition on the first day were granted an additional opportunity to immerse themselves in the vibrant atmosphere, engage with business owners, and benefit from the special offers and discounts being provided by participating vendors. The fair had truly transformed Ghud Park into a bustling marketplace, brimming with an abundance of options to cater to every taste and interest.

From indulging in delectable Ghanaian delicacies and refreshing beverages to discovering trendy clothing, beauty products, footwear, electronics, household essentials, and innovative business solutions, the fair had something for virtually everyone present. The excitement was palpable as shoppers explored the stalls, interacted with local entrepreneurs, and eagerly anticipated the next opportunity to score a great deal.

Written by urgent.news from Joy Business's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at myjoyonline.com →

More in Business

Bristol Myers Squibb's Growth Portfolio Now Brings In $7.7 Billion a Quarter. Here's Why That Changes the Stock's Story.

Bristol Myers Squibb is facing down the expiration of patent protections for older drugs, but new drugs are starting to show promise.

  • Bristol Myers Squibb's growth portfolio generates $7.7 billion quarterly.
  • Legacy portfolio's $4.69 billion comes from Eliquis, with patent expiring in 2028.
  • Dividend payout ratio of 55% with history of supporting dividends during challenges.

More from Saturday 14 November →